0K36

Moody's Corporation

Common Stock · USD · Gettex

DUTT212

Price

$450.23

+0.04%

Cap

Earnings

30d Trend

-3.4%

0K36
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

200% annualised over 90 days

Next earnings:2026-07-23

BRAIN47 SIGNAL

0
WEAK
Risk Level66
Momentum31
Technical54
Fund Quality50
Cost Efficiency50

Raw weighted: 39×Macro 0.99 (1%)=39

RISK

66/100
90d Volatility
199.9%High
ATR %
0.0%Low daily moves
Max Drawdown (1Y)
-50.0%Volatile

MOMENTUM

31/100
12-1M Momentum
-20.5%Strong downtrend
6-1M Momentum
+0.0%Flat
1M Return
+53.8%Strong recent gains

TECHNICAL

54/100
RSI (14)
57.8Neutral
Price vs SMA200
+100.0%Bullish trend
MACD
0.00Bearish momentum
Bollinger Band
100%Near upper band
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.156Noisy/choppy

FUND QUALITY

50/100

COST EFFICIENCY

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 60%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months54
3-12 months72
1-5+ years52

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Moody's Corporation at 39/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 54/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+53.8%

3 MONTHS

+42.9%

12 MONTHS

+33.3%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Technical (54) and Fund Quality (50) are the primary strengths. I note that momentum is the weakest area at 31/100 — this warrants monitoring. Historical volatility is elevated at 200%. I classify this as a growth position — positive trend direction combined with growth potential points to capital appreciation.

growthScore: 39/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.